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Summary
 
Interactions between major histocompatibility complex (MHC) molecules expressed on stro-
mal cells and antigen-specific receptors on T cells shape the repertoire of mature T lympho-
cytes emerging from the thymus. Some thymocytes with appropriate receptors are stimulated
to undergo differentiation to the fully mature state (positive selection), whereas others with
strongly autoreactive receptors are triggered to undergo programmed cell death before com-
pleting this differentiation process (negative selection). The quantitative impact of negative se-
lection on the potentially available repertoire is currently unknown. To address this issue, we
have constructed radiation bone marrow chimeras in which MHC molecules are present on ra-
dioresistant thymic epithelial cells (to allow positive selection) but absent from radiosensitive
hematopoietic elements responsible for negative selection. In such chimeras, the number of
mature thymocytes was increased by twofold as compared with appropriate control chimeras.
This increase in steady-state numbers of mature thymocytes was not related to proliferation, in-
creased retention, or recirculation and was accompanied by a similar two- to threefold increase
in the de novo rate of generation of mature cells. Taken together, our data indicate that half to
two-thirds of the thymocytes able to undergo positive selection die before full maturation due
to negative selection.
 
T
 
lymphocytes express a heterodimeric 
 
ab
 
 TCR that
recognizes peptides bound to cell surface molecules
encoded by the MHC. Whereas TCRs expressed on ma-
ture CD4
 
1
 
 T helper cells respond to peptides associated
with MHC class II, CD8
 
1
 
 cytotoxic cells express MHC
class I–restricted TCRs (1). For effective maturation in the
thymus, precursor T cells need to undergo a suitable inter-
action between their clonotypic TCR and MHC–peptide
ligands expressed on thymic cortical epithelium (2, 3),
though minor exceptions to this rule have been reported
(4–7).
To avoid potentially pathogenic responses to self-pep-
tide–MHC complexes, precursor T lymphocytes are moni-
tored for strong autoreactivity during intrathymic develop-
ment and after emergence in the periphery (8, 9). Many
self-reactive T cells are physically deleted by induction of
programmed cell death. While some clonal deletion can
occur in response to MHC–peptide ligands expressed on
thymic epithelium (10–17), the main cell type involved in
this process is known to be of hematopoietic origin (2). In
normal mice expressing endogenous mouse mammary tu-
mor virus (MMTV)
 
1
 
–encoded superantigens that interact
with TCRs containing particular V
 
b
 
 elements, or in trans-
genic mice with predominant expression of both a single
TCR and its cognate ligand, deletion of developing thymo-
cytes can markedly decrease the total number of T cells un-
dergoing full maturation (18–20). Moreover, in transgenic
mice expressing MHC molecules associated with either a
single or highly predominant peptide, a strong reactivity of
mature T cells to normal syngeneic MHC is observed, in-
dicating that many of these T cells under normal circum-
stances would have been tolerized during development
(21–24). It has recently been shown that thymocytes and
peripheral T cells from mice expressing MHC class II mol-
ecules only on thymic cortical epithelium react to the same
MHC presented by professional APCs (25), confirming
that thymic medullary epithelial cells and hematopoietic el-
ements normally induce T cell tolerance. However, it re-
 
1
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mains unclear whether active deletion of thymocytes poten-
tially capable of effective positive selection in the presence
of the usual diverse array of peptide–MHC complexes dis-
played on thymic stromal cells involves a small or large
proportion of this population. This is a critical issue for a
full understanding of the events involved in intrathymic T cell
development, construction of a useful repertoire, and char-
acterization of the ligands involved in these processes (3).
In this study, we analyze the quantitative impact of thymic
clonal deletion mediated by cells of hematopoietic origin
using bone marrow chimeras with different combinations
of MHC deficiencies.
 
Materials and Methods
 
Mice.
 
Wild-type mice were C57BL/6 (H-2
 
b
 
 haplotype) (see
Fig. 1; Jackson Laboratories, Bar Harbor, ME; other experiments,
Harlan Netherlands, Zeist, The Netherlands). Mice deficient in
MHC class I expression (MHC I
 
8
 
) because of a targeted disrup-
tion of the 
 
b
 
2
 
-microglobulin gene (26) were obtained from Dr.
B. Koller and Genpharm (Mountain View, CA). Mice of H-2
 
b
 
haplotype (I-E
 
a
 
2
 
) with an introduced null mutation in the I-
 
A
 
b
 
b
 
gene (27), and therefore deficient in MHC class II expression
(MHC II
 
8
 
), were obtained from Dr. L. Glimcher and Genpharm
and used in the experiment shown in Fig. 1. In all other experi-
ments, mice deficient in MHC class II expression due to an in-
duced disruption of the I-
 
A
 
a
 
b
 
 gene (28) in C57BL/6 stem cells
(I-E
 
a
 
2
 
) were used (provided by Dr. H. Bluethmann, Basel, Swit-
zerland). MHC I
 
8
 
 and MHC II
 
8
 
 animals were interbred in our fa-
cilities to obtain MHC I
 
8
 
II
 
8
 
 mice. The 
 
b
 
2-microglobulin–defi-
cient mice, as well as the I-
 
A
 
b
 
b
 
 mutants, were crossed at least six
generations to C57BL/6 mice, after which intercrossing yielded
mice homozygous for the disrupted alleles.
 
Chimeras.
 
Chimeras were prepared essentially as described
previously (29). In brief, hosts were lethally irradiated (1,000 rads)
with a Cs
 
137
 
 source and injected the next day i.v. with 10–20 
 
3
 
10
 
6
 
 bone marrow cells depleted of T cells by complement killing
using anti-Thy1 antibody JIJ (30) and anti-Ly1 antibody C3P0
(31) in the experiment shown in Fig. 1 and anti-Thy1 antibody
AT83 (32) in other experiments.
 
Three-color Flow Cytometry.
 
Single-cell suspensions of thymocytes
were incubated on ice with saturating concentrations of the fol-
lowing antibodies: Fig. 1, anti-CD8–FITC, anti-TCR–PE (Phar-
Mingen, San Diego, CA), and anti-CD4–Red613 (GIBCO BRL,
Gaithersburg, MD); Figs. 2 and 4, anti-TCR–FITC (H57-597),
anti-CD4–PE (Boehringer-Mannheim, Mannheim, Federal Re-
public of Germany), and anti-CD8–Red613 (GIBCO BRL, Gai-
thersburg, MD). The samples were analyzed on a FACScan
 
Ò
 
 us-
ing LYSYS II software (Becton Dickinson, Mountain View, CA).
 
Four-Color Flow Cytometry.
 
Single-cell suspensions of thymo-
cytes were incubated on ice with saturating concentrations of the
following antibodies: FITC-labeled anti-CD44 (Pgp-1) mAb
IM7.8.1 (33), FITC-labeled anti-heat soluble antigen (HSA) mAb
M1/69 (34) or FITC-labeled anti-CD69 mAb H1-2F3 (35), com-
bined with anti-TCR–PE (PharMingen, San Diego, CA), anti-
CD8–Red613 (GIBCO BRL, Gaithersburg, MD), and anti-CD4–
bio mAb GK1.5 (36) followed by streptavidin–APC. Four-color
flow cytometry was performed on a FACStar Plus
 
Ò
 
 using LYSYS
II software (Becton Dickinson, Mountain View, CA).
 
Kinetics of Generation of Mature Thymocytes.
 
Chimeras were sub-
lethally irradiated (720 rads, Cs
 
137
 
 source) 6 wk after engraftment
and thymocytes analyzed 9–13 d later by flow cytometry. CD4
 
single-positive (CD4SP) cells are CD4
 
1
 
CD8
 
2
 
TCR
 
high
 
 and CD8SP
cells are CD4
 
2
 
CD8
 
1
 
TCR
 
high
 
.
 
Results and Discussion
 
To determine the quantitative impact of thymic clonal
deletion on the T cell repertoire, we have examined thy-
mocyte development in radiation bone marrow chimeras
of H-2
 
b
 
 haplotype in which MMTV superantigen–medi-
ated deletion is not a significant factor (18, 19). Chimeras
in which the donor bone marrow was from wild-type (wt)
mice and the lethally irradiated host animals were deficient
in both MHC class I and II expression (wt
 
®
 
MHC I
 
8
 
II
 
8
 
chimeras) (37, 38) lacked significant numbers of mature
CD4
 
1
 
8
 
2
 
 or CD4
 
2
 
8
 
1
 
TCR
 
high
 
 thymocytes (CD4SP and
CD8SP, respectively; Fig. 1 
 
A
 
). A quantitative assessment
reveals the development of less than 3% of wt levels of
CD4SP cells and less than 8% of CD8SPs in such chimeras
(Fig. 1 
 
B
 
). These results confirm previous data showing that
efficient positive selection depends on expression of MHC
molecules on radioresistant thymic epithelial cells (2, 3) and
indicate that in the system used here the previously re-
ported low level of T cell differentiation induced by he-
matopoietic elements (4–7) plays a negligible role.
Experiments were then conducted to examine the devel-
opment of mature thymocytes in the absence of the major
characterized source of negative selection signals (2). To
this end, chimeric mice were produced in which MHC
class II was expressed on the radioresistant thymic epithe-
lium to support positive selection of CD4SP cells, but not
on the negatively selecting radiosensitive hematopoietic el-
ements (MHC II
 
8
 
®
 
MHC I
 
8
 
 chimeras). A significant (1.7 
 
6
 
0.2-fold) increase in the steady-state percentage of mature
CD4SP thymocytes was observed in these chimeras as com-
pared with control (MHC II
 
1
 
®
 
MHC I
 
8
 
) chimeras (Fig.
2). As expected, lack of MHC class I on hematopoietic ele-
ments (MHC I
 
8
 
®
 
MHC I
 
8
 
 chimeras) did not result in sig-
nificantly increased CD4SP percentages (1.1 
 
6
 
 0.1-fold) as
compared with appropriate control (MHC I
 
1
 
®
 
MHC I
 
8
 
)
chimeras (Fig. 2). Because thymi from the chimeras had
similar total cell numbers (data not shown), these results re-
flect increases in the absolute number of CD4SP cells.
Thus, in the absence of MHC class II expression on he-
matopoietic elements, a 1.7-fold increase in mature CD4SP
cells occurs, suggesting that approximately half of the posi-
tively selectable thymocytes with receptors specific for self-
MHC class II undergo negative selection on the same
MHC molecule.
Several explanations other than the lack of negative se-
lection could account for the increased number of CD4SP
cells in MHC II
 
8
 
®
 
MHC I
 
8
 
 chimeras. However, prolifera-
tion of mature CD4SP does not account for the increase as
cell cycle analysis reveals no augmentation in the number
of CD4SP cells in S
 
1
 
G2/M phase (Fig. 3 
 
A
 
). A change in
their maturation/export rate could result in an increased
retention of CD4SP cells in the thymus. CD69 is a mole-
cule transiently expressed during thymocyte development:
in vivo, it is first expressed on CD4
 
1
 
CD8
 
1
 
 cells that have 
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undergone MHC-mediated activation and is downmodu-
lated only when the thymocytes have already reached the
SP stage (39–41, 29). The normal ratio of mature thy-
mocytes from the chimeras expressing high versus low lev-
els of CD69 therefore is an indication of normal thymic
maturation (Fig. 3 
 
B
 
). Expression of HSA on CD4SP thy-
mocytes is also downmodulated during their final matura-
tion (42, 43). Again, the normal ratio of HSA
 
high
 
 versus
HSA
 
low
 
 CD4SP cells in the chimeras indicates normal mat-
uration. Taken together, the data on the expression of
CD69 and HSA suggest normal thymocyte development
and render the possibility of prolonged retention of CD4SP
cells in the thymus unlikely. Another possibility would be
the recirculation into the thymus of mature peripheral T cells
(44–46). Peripheral T lymphocytes do not express signifi-
cant levels of HSA (42, 43) and the lack of an increased
percentage of HSA
 
2
 
 CD4SP thymocytes (Fig. 3 
 
B
 
) thus is
inconsistent with a recirculation model. Reentry into the
adult thymus of peripheral T cells is known to be restricted
to activated cells (44–46). These cells may be expected to
express high levels of the memory/activation marker CD44
(47). No evidence for an increase in CD44
 
high
 
 CD4SP thy-
mocytes was found in the chimeras (Fig. 3 
 
B
 
). Collectively,
these data strongly suggest that the increased number of
CD4SP cells in chimeras lacking MHC class II on hemato-
poietic elements is not due to proliferation, to increased re-
tention of thymocytes in the thymus, or to recirculation of
peripheral T lymphocytes.
Analysis of cell number in the steady-state thymus mea-
sures the accumulation rather than the rate of de novo gen-
eration of thymocytes. Because the latter parameter more
directly addresses the issue of whether additional cells are sur-
viving the selection/differentiation process in the absence
of hematopoietic MHC-mediated negative selection, we
analyzed the kinetics of development of mature thymocytes
in MHC-deficient chimeric mice. Most thymocytes are
highly radiosensitive and die upon sublethal irradiation,
whereas a small radioresistant CD4
 
2
 
CD8
 
2
 
 precursor popu-
lation will repopulate the thymus upon such treatment. In
this model system, CD4
 
1
 
CD8
 
1
 
 immature thymocytes ap-
pear around day 6 after irradiation and 3–4 d later mature
SP cells can be observed (41, 48–52). Using this post-irra-
diation repopulation model, we studied the kinetics of gen-
eration of mature thymocytes in bone marrow chimeras
(Fig. 4). In particular, 6 wk after grafting, MHC I
 
8
 
II
 
8
 
®
 
wt,
MHC I
 
8
 
®
 
wt, and control wt
 
®
 
wt chimeras were suble-
Figure 1. Positive selection depends on expression of MHC molecules
on radioresistant thymic epithelial cells. (A) Thymi from wild-type®
wild-type, MHC I8II8®I8II8, and wild-type®I8II8 chimeras were ana-
lyzed by flow cytometry 6 wk after grafting. Thymocytes were stained
with anti-CD8, anti-TCR, and anti-CD4 antibodies and analyzed on a
FACScanÒ using LYSYS II software. Contour plots are 75% logarithmic
and TCR histograms are from total thymus and from electronically gated
cells using the gates indicated in the figure. (B) Percentages of CD4SP
(CD41CD82 TCRhigh) and CD8SP cells (CD42CD81TCRhigh) in thymi
from the indicated chimeras were determined and depicted as percentage
of an age- and sex-matched nonchimeric control mouse 6 SD.
Figure 2. Increased CD4SP (CD41CD82TCRhigh) thymocytes in chi-
meras lacking MHC class II expression on hematopoietic elements.
Groups of sex- and age-matched chimeras were analyzed on the same day
6–8 wk after engraftment. Flow cytometry was performed using anti-
TCR, anti-CD4, and anti-CD8 antibodies. In each experiment, the ratio
of CD4SP cells in the indicated groups was calculated. Error bars indicate
SD. The increased ratio of CD4SP cells in MHC II8®MHC I8 versus
MHC II1®MHC I8 chimeras is statistically significant as assessed by the
Student’s t test (P ,0.0001), whereas the ratio of CD4SP thymocytes in
MHC I8®MHC I8 versus MHC I1®MHC I8 chimeras is not signifi-
cantly increased (P 5 0.02).380 Quantitative Impact of Thymic Clonal Deletion
thally irradiated (720 rads) and their thymi analyzed 9–13 d
later. A significant, approximately twofold greater, genera-
tion of CD4SP thymocytes was observed in the absence of
MHC class II expression on bone marrow–derived cells,
whereas in the absence of MHC class I, CD4SP cells devel-
oped at the same rate as in control chimeras (Fig. 4).
CD8SP thymocytes were also generated more efficiently in
the absence of their negatively selecting ligand (MHC class I)
on hematopoietic elements (Fig. 4). Thus, in MHC I8®wt
and MHC I8II8®wt chimeras a two- to threefold increase
in generation of CD8SP thymocytes was observed. During
the reconstitution no differences in the number of total
thymocytes were seen between the different types of chi-
meras (data not shown), again indicating that absolute in-
creases in SP cells were occurring in these circumstances.
These data confirm that the increase in the number of
CD4SP cells seen in the steady-state thymus of mice lack-
ing MHC class II on hematopoietic cells is due to the lack
of negative selection rather than to alterations in prolifera-
tion, homeostasis, or recirculation of these cells. Moreover,
they reveal a similarly large impact of negative selection on
the development of CD8SP thymocytes.
Collectively, our results indicate that a remarkably large
fraction (half to two-thirds) of thymocytes recognizing li-
gands able to mediate their positive selection do not reach
maturity due to overriding negative selection in the pres-
ence of physiological ligands expressed on hematopoietic
cells. These data, combined with those on the kinetics of
thymocyte development (53, 54), imply that z90% of de-
veloping thymocytes die of neglect and 5% die due to dele-
tion, whereas the remaining 5% survive to populate the pe-
riphery. In considering this calculation, one caveat is that
the proportion of negatively selected thymocytes could
theoretically be larger if some cells are normally deleted de-
spite being unable to be positively selected. However, we
observe no increase in the absolute number of CD41CD81
thymocytes in deletion-deficient chimeras (data not shown),
which is inconsistent with the existence of any appreciable
number of such cells. Therefore, when considering the entire
thymocyte precursor pool, effective signaling for positive
selection places a much greater constraint on the repertoire
than negative selection. This conclusion is also consistent
with a study by Surh and Sprent (55), which showed that
the extent of intrathymic death caused by negative selec-
tion is less than that due to neglect, although no quantitative
estimate of the extent of deletion could be inferred from
these data. However, if one considers only those thymo-
cytes whose interaction with self-peptide–MHC ligands
can initiate the positive selection process necessary for con-
tribution to the functional repertoire, the data presented
here clearly show that many of these cells never complete
maturation, but are eliminated by recognition of the same
class of MHC as that responsible for initiating their differ-
entiation.
Two very recent studies bear on the issue of the fre-
quency of positively selected thymocytes that subsequently
undergo negative selection. Using transgenic mice express-
ing a single peptide–MHC class II complex, Ignatowicz et al.
(22) found that 65% of T cell hybridomas established from
Figure 3. Increase in CD4SP thymocytes in MHC II8®MHC I8 chi-
meras is not due to (A) proliferation or (B) recirculation of peripheral T
lymphocytes. (A) Cell cycle analysis (PI incorporation) was performed on
ethanol-fixed total thymocytes and electronically sorted CD41CD82
TCRhigh cells (purity >95%). Representative results are shown. The sta-
tistics represent mean percentage cells in S1G2/M phase 6 SD from the
indicated number of experiments. (B) Four-color flow cytometry was
performed using anti-CD4, anti-CD8, and anti-TCR antibodies com-
bined with anti-CD44, anti-HSA, or anti-CD69. The CD44, HSA, and
CD69 histograms are of electronically gated CD41CD82TCRhigh cells.
Representative results are shown. The statistics represent mean percent-
age 6 SD from the indicated number of experiments.
Figure 4. Accelerated kinetics of generation of CD4SP and CD8SP
thymocytes in wild-type hosts lacking MHC class II or I, respectively, on
hematopoietic elements. 6-wk-old wt®wt (n 5 3, day 9; n 5 6, days 10–
13), MHC I8II8®wt (n 5 3 each day), and MHC I8®wt (n 5 3) chime-
ras were sublethally irradiated (720 rads) and analyzed on day 9–13 as in
Fig. 2. Data represent average percentage of CD41CD82TCRhigh and
CD42CD81TCRhigh thymocytes 6 SD.381 van Meerwijk et al.
positively selected CD41 cells reacted with wild-type MHC
class II molecules presented by APCs. These data were in-
terpreted to mean that 65% of positively selected thymo-
cytes in these transgenic mice would normally have under-
gone negative selection. However, in another transgenic
model in which MHC class II was expressed only on thy-
mic cortical epithelium, Laufer et al. (25) estimated the fre-
quency of positively selected CD41 cells reactive with MHC
class II on APCs to be only 5% by limiting dilution analysis.
The apparent discrepancy in the frequency estimates of
thymocytes that are potentially subject to negative selection
in these two studies could result from differences in the
transgenic models and/or assay systems used. Whatever the
explanation, it should be emphasized that neither study di-
rectly addresses the extent of thymic clonal deletion, be-
cause the fate of the MHC-reactive cells in these transgenic
systems in vivo could have been either deletion or induc-
tion of anergy.
Based on the requirement for epithelial MHC recogni-
tion in positive selection, the negative selection events me-
diated by hematopoietic MHC molecules here appear to
occur after initiation of this process. This raises the question
of what is different about recognition by partially mature
T cells of MHC ligands on bone marrow–derived cells as
compared with the recognition of possibly the identical
peptide–MHC complex on epithelial cells by immature pre-
cursors, such that the former leads to cell death and the lat-
ter to promotion of differentiation. Two of the most obvi-
ous possibilities are the increased surface expression of TCR
by partially mature cells (56, 57, 41), which could change
the quantity or even quality of signals received by the cell,
and the expression of costimulatory ligands such as CD80/
CD86 on the hematopoietic cells. In some models, the lat-
ter has been shown to contribute to thymocyte death when
combined with TCR signals (58, 59). Whatever the expla-
nation, these data focus attention on the issue of whether
peptides unique to epithelial cells make a predominant contri-
bution to repertoire development. Whereas no epithelium-
specific peptides could be eluted from class II MHC mole-
cules (60), the existence of such tissue-specific ligands has
been demonstrated by transplant experiments (10).
Finally, central (thymic) and peripheral tolerization by
means other than deletion have been described (61, 62). In
this respect, it will be of considerable interest to determine
whether mature T cells from our chimeras that have es-
caped negative selection will respond when confronted
with professional APCs expressing the MHC ligands en-
countered during positive selection.
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